Literature DB >> 10594128

Morphometric analysis of preterm fetal pulmonary development in the sheep model of congenital diaphragmatic hernia.

J Lipsett1, J C Cool, S I Runciman, W D Ford, J D Kennedy, A J Martin, D W Parsons.   

Abstract

Congenital diaphragmatic hernia (CDH) in humans carries high mortality/morbidity attributed to associated pulmonary hypoplasia. An understanding of the effects of CDH on fetal lung growth is important for development of successful treatments. This study aimed to quantitate structural differences between normal and CDH-affected preterm lamb lungs. We hypothesized that (a) pulmonary hypoplasia is present in preterm CDH-affected lungs; (b) the relative degree of pulmonary hypoplasia increases with gestation; and (c) the left upper lobe (LUL) is affected most. Fetal lambs were allocated to two groups. One group underwent surgery (72-74 days gestation) inducing CDH. Both groups (n = 7, n = 7) were delivered by cesarean section at 129 days (term: 145-149). Lungs were obtained at autopsy, were inflation-fixed, processed for histology, and morphometry was performed. Preterm lungs of CDH-affected lambs in comparison to those of normal lambs demonstrated a reduction in the following: lung weight (37.7 g vs. 116.3 g); lung weight:body weight (0.012 vs. 0.040); fixed lung volume (33.6 ml vs. 96.9 ml); gas-exchange surface area (4.56 m(2) vs. 13.70 m(2)); parenchyma:nonparenchyma (59:41 vs. 72:28); and parenchymal airspace:tissue (16:84 vs. 35:65). Non-parenchyma connective tissue was increased (58%), airspaces were more numerous (1077/mm(2)) and smaller (perimeter 76.6 microm), gas-exchange surface density (2394 cm(-1)) was greater and capillary loading (0.04 ml/m(2)) was reduced compared to preterm normal lung (49%; 778/mm(2); 108.7 microm; 2003 cm(-1), 0.11 ml/m(2), respectively). The LUL was affected most. These data quantitate pulmonary hypoplasia in preterm CDH-affected lambs. Comparisons with published data indicate increasing relative hypoplasia as gestation proceeds. Fetal interventions will affect lung development, depending on timing, with intervention still likely to be worthwhile during late gestation.

Entities:  

Mesh:

Year:  2000        PMID: 10594128     DOI: 10.1007/s100240050002

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  6 in total

Review 1.  Animal models in pediatric surgery.

Authors:  A Mortell; S Montedonico; P Puri
Journal:  Pediatr Surg Int       Date:  2005-12-06       Impact factor: 1.827

2.  Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; David A Partrick; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

3.  Antenatal BAY 41-2272 reduces pulmonary hypertension in the rabbit model of congenital diaphragmatic hernia.

Authors:  Aline Vuckovic; Susanne Herber-Jonat; Andreas W Flemmer; Brigitte Strizek; Alexander C Engels; Jacques C Jani
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-12       Impact factor: 5.464

4.  Reduced clearance of respiratory syncytial virus infection in a preterm lamb model.

Authors:  David K Meyerholz; Branka Grubor; Sasha J Fach; Randy E Sacco; Howard D Lehmkuhl; Jack M Gallup; Mark R Ackermann
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

5.  Cortisol enhances structural maturation of the hypoplastic fetal lung in sheep.

Authors:  Rochelle Boland; Belinda J Joyce; Megan J Wallace; Heather Stanton; Amanda J Fosang; Richard A Pierce; Richard Harding; Stuart B Hooper
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

6.  Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia.

Authors:  Sharon Unger; Ian Copland; Dick Tibboel; Martin Post
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.